Phase 2 trial results are expected later this year.
Moderna Inc., the company that shot to fame after developing the vaccine for COVID-19, has teamed up with the pharmaceutical giant, Merck, to develop a personalized vaccine against skin cancer,. If successful, the vaccine will be used in high-risk patients of melanoma, the deadliest known skin cancer.
Moderna's mRNA-4517/V940 is designed to generate Tcell responses based on the mutational signature of the tumor in the patient. T cells are a type of white blood cell that are tasked with defending the body in the event of an infection. use this mechanism to evade T cell attack, using KEYTRUDA even puts healthy cells in the firing line.KEYNOTE-942 trial
Australia Latest News, Australia Headlines
Similar News:You can also read news stories similar to this one that we have collected from other news sources.
Moderna and Merck Will Jointly Develop a Cancer Vaccine for High-Risk Melanoma PatientsModerna's messenger RNA vaccine is being studied in combination with Merck's Keytruda to treat patients with high-risk melanoma, the deadliest form of skin cancer, in a phase two trial.
Read more »
Skin cancer exam should include full body, scalpMelanoma is the most dangerous skin cancer, and the one that doctors most want to find...
Read more »
Making Strides Against Breast Cancer walks in Bay AreaHelp fight breast cancer and raise money for patients and survivors by joining AmericanCancer and KTVU at the upcoming Making Strides Against Breast Cancer walks in San Francisco and Santa Clara. Details:
Read more »
Real Housewives Alum Teddi Mellencamp Diagnosed With Stage 2 Melanoma - E! OnlineReal Housewives alum Teddi Mellencamp has shared her skin cancer diagnosis: 'Moral of this story: If a doctor says, 'Come in every 3 months,' please go in every 3 months.'
Read more »
NYPD, FDNY to play charity baseball games against Ukraine national teamNY’s Bravest and Finest will each play a game against the Ukrainian National team in Brooklyn.
Read more »